Point Of Care Infectious Disease Diagnostics Market
- 2026 年市場規模
- USD 6,834.4 Mn
- 2033 年預估規模
- USD 17,633.5 Mn
- 年複合成長率 CAGR
- 14.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Point Of Care Infectious Disease Diagnostics Market, By Technology (Lateral Flow, Agglutination Assays, Flow-Through, Solid Phase), By Application (HIV, Tropical Disease, Liver Disease, Inflammatory Disease, Respiratory Disease, Hospital Associated Infections (HAIs), Sexual Health Disorders, Others), By End User (Hospitals, Diagnostic Laboratories, Home-Care Settings, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.
Market Dynamics
Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.
Key features of the study
• This report provides in-depth analysis of point of care infectious disease diagnostics market and provides market size (USD Bn) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market
Market Segmentation
• By Technology (Revenue, USD Mn, 2021-2033)
o Lateral Flow
o Agglutination Assays
o Flow-Through
o Solid Phase
• By Application (Revenue, USD Mn, 2021-2033)
o HIV
o Tropical Disease
o Liver Disease
o Inflammatory Disease
o Respiratory Disease
o Hospital Associated Infections (HAIs)
o Sexual Health Disorders
o Others
• By End User (Revenue, USD Mn, 2021-2033)
o Hospitals
o Home-Care Settings
o Diagnostic Laboratories
o Others
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Competitive Landscape
o Danaher Corporation
o Abbott Laboratories
o Alcon Laboratories, Inc.
o Hoffman-La Roche Ltd.
o Becton, Dickinson, and Company
o Trinity Biotech Plc
o AccuBioTech Co., Ltd.
o Cardinal Health, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Technology
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o PEST Analysis
4. Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2021 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Lateral Flow
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Agglutination Assays
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Flow-Through
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Solid Phase
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
5. Global Point of Care Infectious Disease Diagnostics Market, By Application, 2021 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o HIV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Tropical Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Liver Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Inflammatory Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Respiratory Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Hospital Associated Infections (HAIs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Sexual Health Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
6. Global Point of Care Infectious Disease Diagnostics Market, By End User, 2021 – 2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Home-Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
7. Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2021 – 2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022 – 2033
o North America
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o Brazil
o Mexico
o Rest of Latin America
o Africa
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Technology, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Application, 2021 – 2033 (USD Mn)
Market Size and Forecast, By End User, 2021 – 2033 (USD Mn)
Market Size and Forecast, By Country, 2021 – 2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Danaher Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Abbott Laboratories
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Acon Laboratories, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Hoffman-La Roche Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Becton, Dickinson, and Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Trinity Biotech Plc
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
AccuBioTech Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Cardinal Health, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 40 market data tables and 42 figures on Point of Care Infectious Disease Diagnostics Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們